385
Participants
Start Date
October 9, 2024
Primary Completion Date
September 28, 2025
Study Completion Date
September 28, 2025
RSV/hMPV vaccine dose A1
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose A2
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose A3
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose B1
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose B2
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose B3
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose C1
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose C2
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose C3
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose 1
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose 2
Suspension for injection. Route of administration: IM injection
RSV/hMPV vaccine dose 3
Suspension for injection. Route of administration: IM injection
Monovalent RSV Vaccine
Suspension for injection. Route of administration: IM injection
Site # 0361004, Botany
Site # 031001, Brookvale
Site # 0361006, Miranda
Site # 0361002, Wollongong
Site # 0361003, Herston
Site # 0361005, South Brisbane
Sanofi Pasteur, a Sanofi Company
INDUSTRY